CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
The Pattern of Time to Onset and Resolution of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors in Cancer: A Pooled Analysis of 23 Clinical Trials and 8,436 Patients
Si-Qi Tang, Ling-Long Tang, Yan-Ping Mao, Wen-Fei Li, Lei Chen, Yuan Zhang, Ying Guo, Qing Liu, Ying Sun, Cheng Xu, Jun Ma
Cancer Research and Treatment. 2021;53(2):339-354.   Published online 2020 November 6    DOI: https://doi.org/10.4143/crt.2020.790

Excel Download

The Pattern of Time to Onset and Resolution of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors in Cancer: A Pooled Analysis of 23 Clinical Trials and 8,436 Patients
Cancer Research and Treatment. 2021;53(2):339-354   Crossref logo
Link1 Link2 Link3

A meta-analysis of immune-related adverse events (irAE) of immune checkpoint inhibitors (ICI) from cancer clinical trials
Annals of Oncology. 2016;27:vi369   Crossref logo
Link1 Link2 Link3

The quality of reporting general safety parameters and immune-related adverse events in clinical trials of FDA-approved immune checkpoint inhibitors
BMC Cancer. 2020;20(1):   Crossref logo
Link1 Link2 Link3

Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors
Immune Network. 2020;20(1):   Crossref logo
Link1 Link2 Link3

Immune-related Adverse Events in Patients With Cancer Receiving Influenza Vaccination and Immune Checkpoint Inhibitors
Clinical Infectious Diseases. 2019;70(7):1519-1519   Crossref logo
Link1 Link2 Link3

A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors
International Journal of Cancer. 2019;145(3):639-648   Crossref logo
Link1 Link2

Immune related adverse events to immune checkpoint inhibitors
Pathology. 2017;49:S46   Crossref logo
Link1 Link2

The quality of reporting general safety parameters and immune-related adverse events in clinical trials of FDA-approved immune checkpoint inhibitors
. 2020;   Crossref logo
Link1 Link2

The quality of reporting general safety parameters and immune-related adverse events in clinical trials of FDA-approved immune checkpoint inhibitors
. 2020;   Crossref logo
Link1 Link2

Evaluation of the Reporting of Safety and Immune-Related Adverse Events in Clinical Trials of FDA-Approved Immune Checkpoint Inhibitors in Oncology
. 2020;   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.